KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 105 filers reported holding KURA ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,093,000 | +54550.0% | 78,083 | +66637.6% | 0.00% | – |
| Q2 2021 | $2,000 | -99.6% | 117 | -99.4% | 0.00% | -100.0% |
| Q1 2021 | $529,000 | -94.1% | 18,717 | -93.2% | 0.00% | -94.4% |
| Q4 2020 | $8,966,000 | +5.4% | 274,512 | -1.1% | 0.02% | -10.0% |
| Q3 2020 | $8,504,000 | +169980.0% | 277,561 | +98676.2% | 0.02% | – |
| Q2 2020 | $5,000 | +400.0% | 281 | +226.7% | 0.00% | – |
| Q1 2020 | $1,000 | -99.7% | 86 | -99.7% | 0.00% | -100.0% |
| Q4 2019 | $346,000 | -89.6% | 25,128 | -88.6% | 0.00% | -87.5% |
| Q3 2019 | $3,330,000 | +6985.1% | 219,490 | +9015.0% | 0.01% | – |
| Q2 2019 | $47,000 | +1466.7% | 2,408 | +1386.4% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 162 | -8.0% | 0.00% | – |
| Q4 2018 | $2,000 | +100.0% | 176 | +282.6% | 0.00% | – |
| Q3 2018 | $1,000 | -99.5% | 46 | -99.6% | 0.00% | -100.0% |
| Q2 2018 | $206,000 | -17.9% | 11,309 | -15.5% | 0.00% | 0.0% |
| Q1 2018 | $251,000 | +24.9% | 13,391 | +2.0% | 0.00% | 0.0% |
| Q4 2017 | $201,000 | – | 13,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |